Strattera and Hyzaar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Hyzaar (hydrochlorothiazide; losartan potassium). Common drug interactions include dry mouth among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Hyzaar. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Hyzaar?

Hyzaar has active ingredients of hydrochlorothiazide; losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 16,614 Hyzaar users. Check the latest studies of Hyzaar.

On Jul, 27, 2026

17 people who take Strattera and Hyzaar together, and have interactions are studied.

What are the common drug interactions of Strattera and Hyzaar, by gender? *:

female:

Dry mouth
Weight increased
Abnormal dreams
Cough
Diabetes mellitus non-insulin-dependent
Dysphemia (stammering or stuttering)
Fatigue (feeling of tiredness)
Hoarseness (changing voice)
Hyperglycaemia (high blood sugar)
Hypertrophy breast (increase in the volume of breast due to the enlargement of its component cells)

male:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Body temperature increased
Bone density decreased
Constipation
Dizziness
Dry mouth
Dry skin
Emotional distress
Exercise tolerance decreased

What are the common drug interactions of Strattera and Hyzaar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Hyperglycaemia (high blood sugar)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Bone density decreased
Diabetes mellitus non-insulin-dependent
Dry skin
Dysphemia (stammering or stuttering)
Dysuria (painful or difficult urination)
Emotional distress

50-59:

Aspartate aminotransferase increased
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Body temperature increased
Constipation
Dizziness
Dry mouth
Dysuria (painful or difficult urination)
Fatigue (feeling of tiredness)
Hot flush (sudden feelings of heat)

60+:

Cough
Dry mouth
Heart rate increased
Hoarseness (changing voice)
Hypertrophy breast (increase in the volume of breast due to the enlargement of its component cells)
Injection site extravasation (flow of (blood or lymph) from injection site)
Injection site haemorrhage (bleeding from injection site)
Injection site urticaria (rash of round, red welts on the skin at injection site)
Weight increased

What are the existing conditions these people have? *

Depression: 3 people, 17.65%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 11.76%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 11.76%
Mental Disorder Due To A General Medical Condition (abnormal a mental or behavioural pattern due to medicine): 1 person, 5.88%
Memory Loss: 1 person, 5.88%
Hiv Infection: 1 person, 5.88%
High Blood Cholesterol: 1 person, 5.88%
Blood Testosterone Decreased: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Hyzaar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously